ANGLE plc
Market Cap
$3.02M
P/E Ratio
-0.19
EPS
$-0.05
Dividend Yield
0.00%
52-Week Range
$0.85 — $17.45
Volume
132.28K
Avg Volume
5.63M
Beta
0.08
P/E (TTM)
-0.19
Forward P/E
—
PEG Ratio
-0.00
P/S (TTM)
1.32
P/B (TTM)
0.30
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-1.05%
ROA (TTM)
-0.87%
ROIC
—
Gross Margin
0.62%
Operating Margin
-8.12%
Net Margin
—
Debt/Equity
0.31
Current Ratio
3.13
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.06%
EPS Growth (5Y)
+0.04%
Sales Growth (3Y)
+0.48%
Sales Growth (5Y)
+0.33%
EPS Est (This Year)
$-0.04
EPS Est (Next Year)
$-0.04
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
322.53M
Float
238.17M
Free Float %
73.85%
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
GB
Exchange
LSE
IPO Date
2004-03-17
Employees
150
CEO
Andrew David William Newland ACA, Meng
Index Membership
—
Website
https://angleplc.com
ANGLE plc (AGL.L) is a healthcare company in the medical - diagnostics & research industry listed on the LSE. With a market capitalization of $3.02M, a P/E ratio of -0.19, AGL.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare AGL.L against other stocks using dozens of fundamental and technical filters.
ANGLE plc (AGL.L) has a trailing twelve-month (TTM) P/E ratio of -0.19. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, ANGLE plc (AGL.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
ANGLE plc (AGL.L) has a market capitalization of $3.02 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.